More of a little curiosity or some funny pastime while we are waiting for official newsflow reg enrollment or partnering. But it seems as if AI is on our side! ;-)
„Medical trials are as expensive and time consuming as they are vital. But AI has emerged that might well be able to predict results.
Given that, a positive trial result can put a rocket up a biotech company’s share price, while a negative one can send it into a tailspin.
The wonders of artificial intelligence mean that it is possible to predict a trial result with 90 per cent accuracy, according to life-sciences nanocap Opyl.
Opthea (ASX:OPT) has two Phase 3 trials for the eye condition wet aged-related macular degeneration, due to report mid next year. Combining the company’s therapy with different “standard of care” drugs, the trials are rated a solid 63.8 per cent and 52.32 per cent chance of success.“
=> click here <=
To be taken with a grain of smile…
Hang in there!!, page-159
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.045(6.43%) |
Mkt cap ! $806.3M | |||
| Open | High | Low | Value | Volume |
| 69.5¢ | 69.5¢ | 63.0¢ | $2.808M | 4.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49996 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 50869 | 6 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |